| Suprachoroidal Gene Transfer with Nonviral Nanoparticles in Large Animal Eyes M Zhang, JI Shen, RL e Silva, K Luly, S Hackett, S Tzeng, S Lowmaster, ... Investigative Ophthalmology & Visual Science 65 (7), 2228-2228, 2024 | | 2024 |
| GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM H Lopez-Bertoni, S Sall, H Khela, J Korleski, K Luly, M Johnson, B Lal, ... Cancer Research 84 (6_Supplement), 2781-2781, 2024 | | 2024 |
| Nanoparticle-mediated delivery of miR-590-3p decreases recurrent GBM tumor growth by inhibits multiple oncogenic nodes H Lopez-Bertoni, S Sall, H Khela, J Korleski, K Luly, M Johnson, B Lal, ... Cancer Research 84 (6_Supplement), 458-458, 2024 | | 2024 |
| Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes J Shen, R Lima e Silva, M Zhang, KM Luly, SF Hackett, SY Tzeng, ... Science Advances 10 (10), eadl3576, 2024 | | 2024 |
| Non-viral gene delivery to hepatocellular carcinoma via intra-arterial injection HJ Vaughan, CG Zamboni, KM Luly, L Li, KL Gabrielson, LF Hassan, ... International journal of nanomedicine, 2525-2537, 2023 | 3 | 2023 |
| Abstract B009: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM H Lopez-Bertoni, S Sall, H Khela, J Korleski, K Luly, M Johnson, ... Cancer Immunology Research 11 (12_Supplement), B009-B009, 2023 | | 2023 |
| Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo KM Luly, JJ Green, JC Sunshine, SY Tzeng ACS Biomaterials Science & Engineering 9 (11), 6438-6450, 2023 | 1 | 2023 |
| 1181 Delivery of costimulatory molecules and immunostimulatory cytokines leads to targeted and systemic immune activation against melanoma in vivo KM Luly, JJ Green, JC Sunshine, SY Tzeng Journal of Investigative Dermatology 143 (5), S203, 2023 | | 2023 |
| 801 Novel nanoparticles mediate efficient siRNA/mRNA co-delivery to melanoma KM Luly, EE Rocher, JJ Green, SY Tzeng, JC Sunshine Journal of Investigative Dermatology 143 (5), S138, 2023 | | 2023 |
| Biodegradable Polyester Nanoparticle Vaccines Deliver Self‐Amplifying mRNA in Mice at Low Doses DR Wilson, SY Tzeng, Y Rui, SY Neshat, MJ Conge, KM Luly, E Wang, ... Advanced therapeutics 6 (5), 2200219, 2023 | 2 | 2023 |
| Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications J Yang, KM Luly, JJ Green Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 15 (2 …, 2023 | 11 | 2023 |
| Poly (beta-amino ester) s as high-yield transfection reagents for recombinant protein production KM Luly, H Yang, SJ Lee, W Wang, SD Ludwig, HE Tarbox, DR Wilson, ... International journal of nanomedicine 17, 4469, 2022 | 6 | 2022 |
| Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies J Karlsson, KM Luly, SY Tzeng, JJ Green Advanced drug delivery reviews 179, 113999, 2021 | 40 | 2021 |
| 222 Genetic reprogramming of Merkel cell carcinoma and melanoma leads to increased MHC-I expression and antitumor immune activation in vitro and in vivo K Luly, J Green, S Tzeng, J Sunshine Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
| 003 In vitro genetic reprogramming increases MHC-I expression and ameliorates resistance to an antitumor immune response in Merkel cell carcinoma KM Luly, JJ Green, SY Tzeng, JC Sunshine Journal of Investigative Dermatology 141 (5), S1, 2021 | | 2021 |
| Photocrosslinked bioreducible polymeric nanoparticles for enhanced systemic siRNA delivery as cancer therapy J Karlsson, SY Tzeng, S Hemmati, KM Luly, O Choi, Y Rui, DR Wilson, ... Advanced functional materials 31 (17), 2009768, 2021 | 37 | 2021 |
| Safety considerations for nanoparticle gene delivery in pediatric brain tumors KM Luly, J Choi, Y Rui, JJ Green, EM Jackson Nanomedicine 15 (18), 1805-1815, 2020 | 13 | 2020 |
| Abstract B37: development of inhibitors of the activated form of KRAS G12C ML Stewart, NR Perl, SJ Lee, L Xue, M Zhou, J Simon, KM Luly, S Grigoriu, ... Molecular Cancer Research 18 (5_Supplement), B37-B37, 2020 | 1 | 2020 |
| Development of inhibitors of the activated form of KRAS G12C. ML Stewart, NR Perl, SJ Lee, L Xue, M Zhou, J Simon, KM Luly, S Grigoriu, ... MOLECULAR CANCER RESEARCH 18 (5), 70-70, 2020 | | 2020 |
| Development of inhibitors of the activated form of KRAS G12C R Pollock, M Stewart, N Perl, SJ Lee, L Xue, M Zhou, J Simon, K Luly, ... EUROPEAN JOURNAL OF CANCER 103, E52-E52, 2018 | | 2018 |
